From September, these new policies and regulations will affect the pharmaceutical manufacturing industry!

[pharmaceutical network industry trends] the industry once took September as the four confirmation periods of domestic policies and corporate profits Many policies of pharmaceutical manufacturing industry will be implemented in September These new policies and regulations will affect the whole industry, every enterprise and every pharmaceutical person Next, I will make a brief inventory In September, the pharmaceutical manufacturing industry will undergo tremendous changes The measures for the management of medical consumables in medical institutions (for Trial Implementation) was officially implemented from September 1, and the measures for the management of medical consumables in medical institutions (for Trial Implementation) jointly issued by the State Health Commission and the State Administration of traditional Chinese medicine began to be implemented The measures has made relevant requirements on management object, management content, consumables procurement and management system It is required that medical institutions should implement the relevant regulations on the publicity of hospital affairs, include the main medical consumables into the scope of active publicity, and disclose the relevant information such as brand product regulations, suppliers and prices This also means that the procurement of medical consumables will be more transparent and open, and the industry will be further standardized, which is conducive to reducing the cost burden of patients On September 1, Shanghai Sunshine medical network released the document of centralized drug purchase in the alliance area This expansion will be carried out in 25 regions including Shanxi, Inner Mongolia, Liaoning, Jilin, Heilongjiang, Jiangsu and Zhejiang, involving 25 successful products in pilot batches, and introducing new regulations of "multiple winning bids" According to the arrangement, this round of procurement will be opened in Shanghai on September 24 The application materials will be received at 8:30 a.m on the same day, and the application information will be submitted and made public by 10 a.m., and the confirmation will be started at 2 p.m in the supply area, and the results are expected to be available on the same day With the scope of centralized drug purchase gradually spread to the whole country, it is conducive to further reduce the price of drugs and reduce the burden of drug use for patients in China The new version of "drug production license" and other licenses will be enabled According to the notice on enabling the new version of license issued by the State Food and drug administration, the new version of "drug production license" and other licenses will be enabled from September 1 7 kinds of certificates, including the new version of drug production license, preparation license of medical institutions, drug trade license, production license of radioactive drugs, trade license of radioactive drugs, use license of radioactive drugs, qualification certificate of Internet drug information service (including the first and second copies), are uniformly formulated by the state food and drug administration For the license that has not expired in 2019, the drug administration of each province (District, city) shall organize to replace the new license before the end of December 2020, with the validity consistent with the original license If it does not meet the requirements, the certificate shall not be renewed No more paracetamol and oxycodone tablets are allowed to be purchased by unqualified retail pharmacies According to the announcement on the inclusion of oxycodone containing compound preparations and other varieties in the management of psychotropic drugs jointly issued by the State Food and Drug Administration and other three departments, from September 1, 2019, enterprises without the second type of psychotropic drugs business qualification shall not buy any more paracetamol oxycodone tablets, and the original inventory of products shall be registered and reported to the relevant departments in the region where they are located for filing, and shall be sold out as required At the same time, the manufacturers of paracetamol oxycodone tablets need to be equipped with storage conditions and safety management facilities in accordance with the relevant requirements, formulate the corresponding management system, and apply to the local provincial drug supervision and administration department for fixed-point production procedures before January 1, 2020 The varieties including oxycodone compound preparation are listed in the administration of psychotropic drugs According to the provisions of the State Drug Administration and other three departments, from September 1, the varieties including oxycodone compound preparation will be officially listed in the administration of psychotropic drugs.